Atlas Trials

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Clinical trial NCT00290251 · COMPLETED

Trial details

NCT number
NCT00290251
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leiomyoma
Start date
2006-02-01
Primary completion
2009-07-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.